Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $12.87B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $32.46B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $6.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.33B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $2.25B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $12.21B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $2.23B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $10.16B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $35.49B | 1.50% | 48.40% | $0.2350 | $0.93 | 34% | 0 | 2026-09-10 | |
| TGTX | TG THERAPEUTICS INC | $7.91B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $720.33M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $13.42B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $250.83M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LGND | LIGAND PHARMACEUTICALS INC | $5.80B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $139.93B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $16.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPRO | SPERO THERAPEUTICS INC | $71.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $11.35B | 0.44% | 45.10% | $0.0800 | $0.32 | 8% | 1 | ||
| MDXG | MIMEDX GROUP INC | $648.63M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $13.48B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UTHR | UNITED THERAPEUTICS CORP | $22.70B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $86.57B | 0.44% | 8.70% | $0.9400 | $3.70 | 8% | 0 | 2026-08-31 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.33B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $26.04B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.